Form 8-K

8-K — SPLASH BEVERAGE GROUP, INC.

Accession: 0001731122-26-001120

Filed: 2026-08-21

Period: 2026-08-21

CIK: 0001553788

SIC: 2080 (BEVERAGES)

Item: Regulation FD Disclosure

Item: Financial Statements and Exhibits

Documents

8-K — e7881_8-k.htm (Primary)

EX-99.1 — EXHIBIT 99.1 (e7881_ex99-1.htm)

XML — IDEA: XBRL DOCUMENT (R1.htm)

8-K — FORM 8-K

8-K (Primary)

Filename: e7881_8-k.htm · Sequence: 1

false

0001553788

2026-08-21

iso4217:USD

xbrli:shares

iso4217:USD

xbrli:shares

UNITED

STATES

SECURITIES

AND EXCHANGE COMMISSION

Washington,

D.C. 20549

FORM

8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of The Securities

Exchange Act of 1934

Date of Report (Date of earliest event reported):

August 21, 2026

SPLASH

BEVERAGE GROUP, INC.

(Exact name of registrant as specified in its charter)

Nevada

001-40471

34-1720075

(State or other Jurisdiction

of Incorporation)

(Commission File Number)

(IRS Employer

Identification No.)

1112 N. Flagler Drive

Fort Lauderdale, Florida

33304

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including area

code: (954) 648-7238

Check the appropriate box below if the Form 8-K filing

is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an

emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange

Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☐

If an emerging growth company, indicate by check mark

if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards

provided pursuant to Section 13(a) of the Exchange Act. ☐

Securities registered pursuant to Section 12(b) of

the Act:

Title of Each Class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, $0.001 par value

SBEV

NYSE American LLC

Item 7.01 Regulation FD Disclosure

On August 21, 2026, Splash Beverage Group, Inc. (the “Company”)

issued a press release announcing that its corporate name will change to Endovia Health Sciences, Inc., and its common stock will begin

trading on the NYSE American under the new ticker symbol “EDVA” effective at market open at 9:30 a.m. Eastern Time on Monday,

August 24, 2026.

The name and ticker change mark an important milestone in the Company’s

ongoing strategic transformation from its legacy beverage operations into a diversified cannabinoid-based health sciences platform.

A copy of the press release is furnished as Exhibit

99.1 of this Current Report on Form 8-K.

The information in this Item 7.01 (including Exhibit

99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”)

or otherwise subject to the liabilities under such section, and shall not be deemed to be incorporated by reference into any filing of

the Company under the Securities Act of 1933 or the Exchange Act.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits

Exhibit

Description

99.1

Press Release dated August 21, 2026

104

Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of

the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto

duly authorized.

SPLASH BEVERAGE GROUP, INC.

Date: August 21, 2026

By:

/s/ Brady Cobb

Name:

Brady Cobb

Title:

Interim Chief Executive Officer

EX-99.1 — EXHIBIT 99.1

EX-99.1

Filename: e7881_ex99-1.htm · Sequence: 2

EXHIBIT 99.1

Splash Beverage Group to Become Endovia Health Sciences; New NYSE American

Ticker “EDVA” Effective Monday

New corporate identity and ticker reflect the Company’s transformation

into a diversified cannabinoid-based health sciences platform

FORT LAUDERDALE, Fla., August 21, 2026 — Splash Beverage Group, Inc.

(NYSE American: SBEV) (the “Company”) today announced that its corporate name will change to Endovia Health Sciences, Inc.,

and its common stock will begin trading on the NYSE American under the new ticker Times New Roman, Times, Serif “EDVA” effective at market open at

9:30 a.m. Eastern Time on Monday, August 24, 2026.

The name and ticker change mark an important milestone in the Company’s

ongoing strategic transformation from its legacy beverage operations into a diversified cannabinoid-based health sciences platform.

The Company’s new corporate identity reflects its focus on three

complementary areas: commercial pharmaceutical assets, FDA-regulated human and veterinary therapeutics, and cannabinoid-based consumer

wellness and beverage products.

“This is more than a change in our name and ticker—it reflects

the transformation of our business and the strategy we are executing,” said Brady Cobb, Interim Chief Executive Officer. “Over

the past year, we began repositioning the Company around cannabinoid-based health sciences, acquiring differentiated pharmaceutical rights,

expanding international commercialization opportunities and advancing CannEpil® through regulated human and veterinary development

pathways.”

“Beginning Monday, investors will know us as Endovia Health Sciences,

trading under the Times New Roman, Times, Serif EDVA. We believe the new identity better represents the business we are building and provides a platform from

which we can execute our long-term strategy.”

Building Endovia Health Sciences

Endovia is building a diversified cannabinoid-based health sciences platform

designed to translate science into regulated therapies and trusted health and wellness products for people and animals.

The Company’s strategy is centered on three complementary growth

engines:

● Commercial

Pharmaceutical Assets — Commercializing differentiated cannabinoid-based pharmaceutical

products through international distribution and strategic partnerships.

● FDA-Regulated

Therapeutics — Advancing cannabinoid-based human and veterinary therapeutics through

established U.S. regulatory pathways.

● Consumer

Wellness & Beverages — Developing cannabinoid-based wellness and beverage products

as regulatory frameworks and commercial opportunities evolve.

The Company recently advanced its CannEpil® veterinary development

program by opening an Investigational New Animal Drug (INAD) file with the U.S. Food and Drug Administration’s Center for Veterinary

Medicine, establishing the regulatory framework for the program’s continued development in the United States.

“Our focus now is execution,” Cobb continued. “We have

established the platform, expanded our pharmaceutical and veterinary opportunities, and created a corporate identity that aligns with

our direction. The next phase is about achieving measurable regulatory and commercial milestones and building long-term value for our

shareholders.”

New Corporate Identity

Effective Monday, August 24, 2026:

Corporate Name: Endovia Health Sciences, Inc.

NYSE American Ticker: EDVA

Trading Effective: 9:30 a.m. Eastern Time

Corporate Website: EndoviaSciences.com

The name and ticker change will not affect the rights of the Company’s

shareholders. Existing stock certificates will remain valid, and no action is required by shareholders in connection with the change.

Our Vision

To build a diversified cannabinoid-based health sciences platform that

translates science into regulated therapies and trusted health and wellness products for people and animals.

Our Mission

Endovia Health Sciences acquires, develops and commercializes differentiated

cannabinoid-based health technologies across pharmaceutical, veterinary and consumer wellness markets. Through disciplined capital allocation,

scientific excellence and strategic partnerships, we strive to build scalable businesses designed to deliver meaningful healthcare innovation

and long-term shareholder value.

About Endovia Health Sciences, Inc.

Endovia Health Sciences, Inc. is prioritizing its efforts toward building

a diversified cannabinoid-based health sciences platform focused on acquiring, developing and commercializing differentiated cannabinoid-based

health technologies across pharmaceutical, veterinary and consumer wellness markets. The Company’s strategy combines international

pharmaceutical commercialization, FDA-regulated human and veterinary development, and cannabinoid-based consumer wellness and beverage

opportunities.

Where Science Meets Cannabinoid Innovation.

Cautionary Note Regarding Forward-Looking Statements

This press release contains

forward-looking statements within the meaning of applicable securities laws, including statements regarding the Company’s strategic

focus and transformation, name change, efforts toward the development and commercialization of CannEpil®, and FDA-regulated pharmaceutical

products for humans and animals, international expansion and future business opportunities, consumer wellness and beverage opportunities,

FDA regulatory activities, anticipated trends and expectations for the Company’s

business and industry and goals and expectations with respect to the Company’s

new business strategy as well as the Company’s

ability to achieve regulatory, commercial and financial milestones.

Forward-looking statements are based on current expectations and

assumptions and involve risks and uncertainties that could cause actual results to differ materially. These risks include the

Company’s ability to raise the necessary capital to finance the its operations and business and product development plan,

satisfy its contractual obligations including our ability to maintain the license under the license agreement for the CannEpil®

product on which the Company’s initial focus depends and related agreements in connection therewith, our ability to complete

required studies, establish product safety and efficacy, obtain and maintain regulatory authorizations, protect intellectual

property and the risk that competitors market the same or similar products, our ability execute commercialization or

strategic-partnering arrangements, the risk that that the market or demand for any resulting product we seek to commercialize in the

future could be less than expected or projected, our ability to meet our debt obligations and the negative financial and operational

consequences of failing to do so, our ability to comply with NYSE American’s continued listing standards and the risk that we

may be delisted, the possibility that our expectations and perceived benefits with respect to our business and product development

plan and strategic transactions we may pursue prove to be incorrect, and risks with respect to our ability to negotiate and execute

definitive agreements, satisfy closing conditions, obtain required approvals with respect to any such strategic transaction. There

can be no assurance that the Company’s goals and milestones will be achieved, that the Company or its collaborators will

receive or maintain necessary regulatory authorizations or that any initiative will ultimately generate revenue.

Additional risks are described in the Company’s filings with the

Securities and Exchange Commission, including its Annual Report on Form 10-K for the year ended December 31, 2025 and the Form S-1/A filed

on August 20, 2026. The Company undertakes no obligation to update forward-looking statements except as required by applicable law.

XML — IDEA: XBRL DOCUMENT

XML

Filename: R1.htm · Sequence: 7

v3.26.1

Cover

Aug. 21, 2026

Cover [Abstract]

Document Type

8-K

Amendment Flag

false

Document Period End Date

Aug. 21, 2026

Entity File Number

001-40471

Entity Registrant Name

SPLASH

BEVERAGE GROUP, INC.

Entity Central Index Key

0001553788

Entity Tax Identification Number

34-1720075

Entity Incorporation, State or Country Code

Entity Address, Address Line One

1112 N. Flagler Drive

Entity Address, City or Town

Fort Lauderdale

Entity Address, State or Province

Entity Address, Postal Zip Code

33304

City Area Code

(954)

Local Phone Number

648-7238

Written Communications

false

Soliciting Material

false

Pre-commencement Tender Offer

false

Pre-commencement Issuer Tender Offer

false

Title of 12(b) Security

Common Stock, $0.001 par value

Trading Symbol

SBEV

Security Exchange Name

NYSEAMER

Entity Emerging Growth Company

false

- Definition

Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.

+ References

No definition available.

+ Details

Name:

dei_AmendmentFlag

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Area code of city

+ References

No definition available.

+ Details

Name:

dei_CityAreaCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Cover page.

+ References

No definition available.

+ Details

Name:

dei_CoverAbstract

Namespace Prefix:

dei_

Data Type:

xbrli:stringItemType

Balance Type:

Period Type:

duration

- Definition

For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.

+ References

No definition available.

+ Details

Name:

dei_DocumentPeriodEndDate

Namespace Prefix:

dei_

Data Type:

xbrli:dateItemType

Balance Type:

Period Type:

duration

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.

+ References

No definition available.

+ Details

Name:

dei_DocumentType

Namespace Prefix:

dei_

Data Type:

dei:submissionTypeItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 1 such as Attn, Building Name, Street Name

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine1

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the City or Town

+ References

No definition available.

+ Details

Name:

dei_EntityAddressCityOrTown

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Code for the postal or zip code

+ References

No definition available.

+ Details

Name:

dei_EntityAddressPostalZipCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the state or province.

+ References

No definition available.

+ Details

Name:

dei_EntityAddressStateOrProvince

Namespace Prefix:

dei_

Data Type:

dei:stateOrProvinceItemType

Balance Type:

Period Type:

duration

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityCentralIndexKey

Namespace Prefix:

dei_

Data Type:

dei:centralIndexKeyItemType

Balance Type:

Period Type:

duration

- Definition

Indicate if registrant meets the emerging growth company criteria.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityEmergingGrowthCompany

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.

+ References

No definition available.

+ Details

Name:

dei_EntityFileNumber

Namespace Prefix:

dei_

Data Type:

dei:fileNumberItemType

Balance Type:

Period Type:

duration

- Definition

Two-character EDGAR code representing the state or country of incorporation.

+ References

No definition available.

+ Details

Name:

dei_EntityIncorporationStateCountryCode

Namespace Prefix:

dei_

Data Type:

dei:edgarStateCountryItemType

Balance Type:

Period Type:

duration

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityRegistrantName

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityTaxIdentificationNumber

Namespace Prefix:

dei_

Data Type:

dei:employerIdItemType

Balance Type:

Period Type:

duration

- Definition

Local phone number for entity.

+ References

No definition available.

+ Details

Name:

dei_LocalPhoneNumber

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 13e

-Subsection 4c

+ Details

Name:

dei_PreCommencementIssuerTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14d

-Subsection 2b

+ Details

Name:

dei_PreCommencementTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Title of a 12(b) registered security.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b

+ Details

Name:

dei_Security12bTitle

Namespace Prefix:

dei_

Data Type:

dei:securityTitleItemType

Balance Type:

Period Type:

duration

- Definition

Name of the Exchange on which a security is registered.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection d1-1

+ Details

Name:

dei_SecurityExchangeName

Namespace Prefix:

dei_

Data Type:

dei:edgarExchangeCodeItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14a

-Subsection 12

+ Details

Name:

dei_SolicitingMaterial

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Trading symbol of an instrument as listed on an exchange.

+ References

No definition available.

+ Details

Name:

dei_TradingSymbol

Namespace Prefix:

dei_

Data Type:

dei:tradingSymbolItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 230

-Section 425

+ Details

Name:

dei_WrittenCommunications

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration